Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 401–500 of 999
A Novel Molecular Signature for Elevated Tricuspid Regurgitation Velocity in Sickle Cell Disease
Desai, A. A., Zhou, T., Ahmad, H., Zhang, W., Mu, W., Trevino, S., Wade, M. S., Raghavachari, N., Kato, G. J., Peters-Lawrence, M. H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0057oc · Cited by 41
Brandow, A. M., Wandersee, N. J., Dasgupta, M., Hoffmann, R. G., Hillery, C. A., Stucky, C. L., & Panepinto, J. A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14300 · Cited by 47
Ataga, K. I., Derebail, V. K., Caughey, M. C., Elsherif, L., Shen, J. H., Jones, S., Maitra, P., Pollock, D. M., Cai, J., Archer, D. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162652 · Cited by 44
Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease
O’Driscoll, S., Height, S. E., Dick, M. C., & Rees, D. C. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06894.x · Cited by 48
Cita, K.-C., Brureau, L., Lemonne, N., Billaud, M., Connes, P., Ferdinand, S., Tressières, B., Tarer, V., Etienne‐Julan, M., Blanchet, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154866 · Cited by 43
Humbert, M. J. C., Khaltaev, N., Bousquet, J. J., & Souza, R. (2007) · CHEST Journal · doi:10.1378/chest.07-0903 · Cited by 44
Caughey, M. C., Poole, C., Ataga, K. I., & Hinderliter, A. L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13447 · Cited by 41
Update in Pulmonary Hypertension 2008
Humbert, M. J. C. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0136up · Cited by 44
Diagnosis of Pulmonary Arterial Hypertension
Trow, T. K., & McArdle, J. R. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.001 · Cited by 51
Schaefer, B. A., Flanagan, J. M., Alvarez, O. A., Nelson, S. C., Aygün, B., Nottage, K. A., George, A., Roberts, C. W., Piccone, C. M., Howard, T. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164364 · Cited by 42
Definition and Classification of Pulmonary Hypertension
Humbert, M. J. C., Montani, D., Evgenov, O. V., & Simonneau, G. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_1 · Cited by 41
Ancestry of African Americans with sickle cell disease
Solovieff, N., Hartley, S. W., Baldwin, C. T., Klings, E. S., Gladwin, M. T., Taylor, J. G., Kato, G. J., Farrer, L. A., Steinberg, M. H., & Paola Sebastiani, B. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.04.002 · Cited by 40
Self-citationRees, D. C., Dick, M. C., Height, S. E., O'Driscoll, S., Pohl, K. R. E., Goss, D. E., & Deane, C. R. (2008) · Pediatrics · doi:10.1542/peds.2007-2771 · Cited by 40
Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches
Xu, J. Z., & Thein, S. L. (2022) · Blood · doi:10.1182/blood.2021013873 · Cited by 48
Pulmonary Artery Pressures in School-Age Children Born Prematurely
Zivanovic, S., Pushparajah, K., Calvert, S., Marlow, N., Razavi, R., Peacock, J. L., & Greenough, A. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.08.034 · Cited by 39
Turpin, M., Chantalat‐Auger, C., Parent, F., Driss, F., Lionnet, F., Habibi, A., Maître, B., Huertas, A., Jaïs, X., Weatherald, J. C., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00272-2018 · Cited by 42
Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
Kalpatthi, R. V., & Novelli, E. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.482 · Cited by 51
Aging in Sickle Cell Disease: Co-morbidities and New Issues in Management
Sandhu, M. K., & Cohen, A. J. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1040493 · Cited by 39
Qureshi, N., Joyce, J. J., Qi, N., & Chang, R. R. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.055 · Cited by 39
No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension
van Beers, E. J., Spronk, H. M. H., Cate, H. T., Duits, A. J., Brandjes, D. P. M., van Esser, J. W. J., Biemond, B. J., Schnog, J. B., & on behalf of the CURAMA study Group (2008) · Haematologica · doi:10.3324/haematol.12632 · Cited by 39
Epidemiology of Pulmonary Arterial Hypertension
Taichman, D. B., & Mandel, J. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.012 · Cited by 42
The burden of pulmonary hypertension
Humbert, M. J. C. (2007) · European Respiratory Journal · doi:10.1183/09031936.00055407 · Cited by 38
Pulmonary hypertension in well-transfused thalassemia major patients
Meloni, A., Detterich, J. A., Pepe, A., Harmatz, P., Coates, T. D., & Wood, J. C. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.11.003 · Cited by 42
Right Ventricular Systolic Strain Is Altered in Children with Sickle Cell Disease
Blanc, J., Stos, B., de Montalembert, M., Bonnet, D., & Boudjemline, Y. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2012.01.011 · Cited by 39
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease
Paul, R. N., Minniti, C. P., Nouraie, M. S., Luchtman‐Jones, L., Campbell, A., RANA, S. R., Onyekwere, O. C., Darbari, D. S., Ajayi, O., Arteta, M., et al. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12118 · Cited by 43
Self-citation2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension - web addenda
Galiè, N., Humbert, M. J. C., Vachiéry, J., Gibbs, S., Lang, I. M., Torbicki, A., Simonneau, G., Peacock, A. J., Noordegraaf, A. V., Beghetti, M., et al. (2015) · European Respiratory Journal · Cited by 40
Tuijn, C. F. J. V., Schimmel, M., van Beers, E. J., Nur, E., & Biemond, B. J. (2017) · American Journal of Hematology · doi:10.1002/ajh.24855 · Cited by 39
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease
Savale, L., Habibi, A., Lionnet, F., Maître, B., Cottin, V., Jaïs, X., Chaouat, A., Artaud-Macari, É., Canuet, M., Prévôt, G., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00585-2019 · Cited by 41
Vascular complications of sickle cell disease
Usmani, A., & Machado, R. F. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189008 · Cited by 40
Patel, N. N., Sundaram, N., Yang, M., Madigan, C., Kalra, V. K., & Malik, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101691 · Cited by 43
Ahmad, H., Gayat, É., Yodwut, C., Abduch, M. C. D., Patel, A. R., Weinert, L., Desai, A. A., Tsang, W., Garcia, J. G. N., Lang, R. M., et al. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01710.x · Cited by 37
Pulmonary and Systemic Vascular Resistances After Cardiopulmonary Bypass: Role of Hemolysis
Rezoagli, E., Ichinose, F., Strelow, S., Roy, N., Shelton, K., Matsumine, R., Chen, L., Bittner, E. A., Bloch, D. B., Zapol, W. M., et al. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.06.009 · Cited by 42
Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance
Chaudry, R. A., Cikes, M., Karu, T., Hutchinson, C., Ball, S. E., Sutherland, G. R., Rosenthal, M., Bush, A., & Crowley, S. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2010.184028 · Cited by 38
Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function
Hagar, R. W., Morris, C. R., & Vichinsky, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06053.x · Cited by 40
Dense red blood cell and oxygen desaturation in sickle‐cell disease
Liberto, G. D., Kiger, L., Marden, M. C., Boyer, L., Canouï‐Poitrine, F., Conti, M., Rakotoson, M. G., Habibi, A., Khorgami, S., Vingert, B., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24467 · Cited by 41
Pulmonary Hypertension in Sickle Cell Disease
Hayes, M. M., Vedamurthy, A., George, G., Dweik, R. A., Klings, E. S., Machado, R. F., Gladwin, M. T., Wilson, K. C., & Thomson, C. C. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201408-405cme · Cited by 36
Self-citationSarode, R., Ballas, S. K., Garcia, A., Kim, H. C., King, K. E., Sachais, B. S., & Williams, L. A. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21511 · Cited by 38
Hoppe, C. C., & Neumayr, L. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.01.014 · Cited by 44
Increased QT Dispersion in Sickle Cell Disease: Effect of Pulmonary Hypertension
Akgül, F., Seyfeli, E., Melek, İ., Duman, T., Seydaliyeva, T., Gali, E., & Yalçın, F. (2007) · Acta Haematologica · doi:10.1159/000100929 · Cited by 38
Kutlar, A., Reid, M. E., Inati, A. C., Taher, A. T., Abboud, M. R., El-Beshlawy, A. M., Buchanan, G. R., Smith, H. P., Ataga, K. I., Perrine, S. P., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23533 · Cited by 39
Nouraie, M. S., Darbari, D. S., RANA, S. R., Minniti, C. P., Castro, O. L., Luchtman‐Jones, L., Sable, C., Dham, N., Kato, G. J., Gladwin, M. T., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25799 · Cited by 39
Self-citationCystatin C: A useful marker of glomerulopathy in sickle cell disease?
Asnani, M., & Reid, M. E. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.07.018 · Cited by 35
Autonomic nervous system dysfunction: Implication in sickle cell disease
Connes, P., & Coates, T. D. (2012) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2012.09.003 · Cited by 38
Clinical hemoglobinopathies: iron, lungs and new blood
Morris, C. R., Singer, S. T., & Walters, M. C. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.moh.0000245685.24462.4e · Cited by 35
How I treat sickle cell disease with hematopoietic cell transplantation
Stenger, E. O., Shenoy, S. S., & Krishnamurti, L. (2019) · Blood · doi:10.1182/blood.2019000821 · Cited by 37
Zimbarra Cabrita, I., Mohammed, A., Layton, M., Ghorashian, S., Gilmore, A., Cho, G., Howard, J., Anie, K. A., Desforges, L., Bassett, P., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12391 · Cited by 34
Delivering telemedicine interventions in chronic respiratory disease
Hernández, C., Mallow, J. A., & Narsavage, G. L. (2014) · Breathe · doi:10.1183/20734735.008314 · Cited by 38
Pulmonary Arterial Hypertension: Yesterday, Today, Tomorrow
Michelakis, E. D. (2014) · Circulation Research · doi:10.1161/circresaha.115.301132 · Cited by 36
Hematopoietic Cell Transplantation for Sickle Cell Disease
Krishnamurti, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.551170 · Cited by 37
Pulmonary arterial hypertension in children: a medical update
Rosenzweig, E. B., & Barst, R. J. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282ff5fdc · Cited by 34
Li, C., Mpollo, M. E. M., Gonsalves, C. S., Tahara, S. M., Malik, P., & Kalra, V. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600775 · Cited by 36
Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia
Quinn, C. T., & Miller, S. T. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.07.004 · Cited by 38
Worldwide Physician Education and Training in Pulmonary Hypertension
Elliott, C. G., Barst, R. J., Seeger, W., Porres‐Aguilar, M., Brown, L. M., Zamanian, R. T., & Rubin, L. J. (2010) · CHEST Journal · doi:10.1378/chest.09-2816 · Cited by 34
Liem, R. I., Nevin, M., Prestridge, A. L., Young, L., & Thompson, A. A. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.20996 · Cited by 36
Linguraru, M. G., Pura, J. A., Uitert, R. L. V., Mukherjee, N., Summers, R. M., Minniti, C. P., Gladwin, M. T., Kato, G. J., Machado, R. F., & Wood, B. J. (2010) · Medical Physics · doi:10.1118/1.3355892 · Cited by 33
Self-citationEnuresis Is a Common and Persistent Problem Among Children and Young Adults with Sickle Cell Anemia
Field, J. J., Austin, P. F., An, P., Yan, Y., & DeBaun, M. R. (2008) · Urology · doi:10.1016/j.urology.2008.02.006 · Cited by 34
Gutiérrez, M., Fish, M. B., Golinski, A. W., & Eniola‐Adefeso, O. (2018) · Langmuir · doi:10.1021/acs.langmuir.7b03890 · Cited by 34
Sickle Cell Anemia in the Female Patient
McKenzie, N. D., Gilles, J. M., Jacques, E., & Harrington, T. J. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000216976.15100.29 · Cited by 33
Barbosa, M. M., Vasconcelos, M. C. M., Ferrari, T. C. A., Fernandes, B. M., Passaglia, L. G., Silva, C. M., & Nunes, M. C. P. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.014 · Cited by 34
Inhaled nitric oxide therapy in children
Kinsella, J. P., & Abman, S. H. (2005) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2005.06.002 · Cited by 33
Cusack, R. A. F., Bos, L. D. J., Póvoa, P. M. S. R., & Martín‐Loeches, I. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1203827 · Cited by 41
Pulmonary Hypertension Associated with Left-Sided Heart Disease
Barnett, C. F., & Marco, T. D. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.04.009 · Cited by 35
The trials and hopes for drug development in sickle cell disease
Ataga, K. I., & Stocker, J. W. (2015) · British Journal of Haematology · doi:10.1111/bjh.13548 · Cited by 33
Nitric Oxide in Cardiac Surgery: A Review Article
Олегович, К. Н., Duong, N., & Berra, L. M. (2023) · Biomedicines · doi:10.3390/biomedicines11041085 · Cited by 38
Prolongation of QT c intervals and risk of death among patients with sickle cell disease
Upadhya, B., Ntim, W. O., Stacey, R. B., Henderson, R., Leedy, D., O’Brien, F. X., & Knovich, M. A. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12127 · Cited by 34
Pulmonary complications of haematopoietic cell transplantation in children
Michelson, P. H., Goyal, R. K., & Kurland, G. (2006) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2006.04.003 · Cited by 34
Genetic Modifiers of Sickle Cell Disease
Thein, S. L. (2011) · Hemoglobin · doi:10.3109/03630269.2011.615876 · Cited by 40
Has stem cell transplantation come of age in the treatment of sickle cell disease?
Shenoy, S. S. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705779 · Cited by 33
Tzortzis, V., Mitrakas, L., Gravas, S., Mamoulakis, C., Meißner, A., Kyriakou, D., & Melekos, M. D. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01285.x · Cited by 32
Teixeira, R., Terse-Ramos, R., Ferreira, T. A., Machado, V. R., Perdiz, M. I., Lyra, I. M., Nascimento, V. M. L., Boa‐Sorte, N., Andrade, B. B., & Ladeia, A. M. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184076 · Cited by 41
Franceschi, L. D., Platt, O. S., Malpeli, G., Janin, A., Scarpa, A., Lebœuf, C., Beuzard, Y., Payen, E., & Brugnara, C. (2008) · The FASEB Journal · doi:10.1096/fj.07-098921 · Cited by 34
Severe Pulmonary Hypertension: The Role of Metabolic and Endocrine Disorders
Bogaard, H. J., Husseini, A. A., Farkas, L., Farkas, D., Gomez‐Arroyo, J. G., Abbate, A., & Voelkel, N. F. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.97592 · Cited by 31
Möckesch, B., Connes, P., Charlot, K., Skinner, S. C., Hardy‐Dessources, M., Romana, M., Jumet, S., Petras, M., Divialle‐Doumdo, L., Martin, C., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14693 · Cited by 34
Antwi‐Boasiako, C., Andemariam, B., Colombatti, R., Asare, E. V., Strunk, C. J., Piccone, C. M., Manwani, D. G., Boruchov, D., Farooq, F., Urbonya, R., et al. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04057-8 · Cited by 38
Automated Red Cell Exchange in the Management of Sickle Cell Disease
Tsitsikas, D. A., Badle, S., Hall, R., Meenan, J., Bello‐Sanyaolu, O., Orebayo, F., Abukar, J., Elmi, M., Mulla, A., Dave, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040767 · Cited by 31
Concepts of Contraception for Adolescent and Young Adult Women with Chronic Illness and Disability
Greydanus, D. E., Pratt, H. D., & Patel, D. R. (2012) · Disease-a-Month · doi:10.1016/j.disamonth.2012.02.001 · Cited by 41
Johnson, C. S. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.08.001 · Cited by 33
Versatile cell ablation tools and their applications to study loss of cell functions
Liu, F., Dai, S., Feng, D., Peng, X., Qin, Z., Kearns, A. C., Huang, W., Chen, Y., Ergün, S., Wang, H., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03243-w · Cited by 36
Taksande, A. M., Jameel, P. Z., Pujari, D., Taksande, B., & Meshram, R. J. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.39.140.28755 · Cited by 34
Onalo, R., Cilliers, A. M., Cooper, P., & Morris, C. R. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1930oc · Cited by 37
Hematopoietic Stem Cell Transplantation for Hemoglobinopathies: Current Practice and Emerging Trends
Smiers, F. J. W., Krishnamurti, L., & Lucarelli, G. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.01.003 · Cited by 32
Cardiac assessment of patients for haematopoietic stem cell transplantation
Coghlan, G., Handler, C. E., & Kottaridis, P. D. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.09.005 · Cited by 30
Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin
Nekhai, S., Xu, M., Foster, A., Kasvosve, I., Diaz, S., Machado, R. F., Castro, O. L., Kato, G. J., Taylor, J. G., & Gordeuk, V. R. (2013) · Haematologica · doi:10.3324/haematol.2012.066530 · Cited by 31
Self-citationGonsalves, C. S., & Kalra, V. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000660 · Cited by 36
Armstrong, G. T., Joshi, V. M., Zhu, L., Srivastava, D. K., Zhang, N., Ness, K. K., Stokes, D. C., Krasin, M. J., Fowler, J. A., Robison, L. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0702 · Cited by 29
Mahesh, B., Besser, M. W., Ravaglioli, A., Pepke‐Żaba, J., Martinez, G. C., Klein, A. A., Ng, C. Y., Tsui, S. S. L., Dunning, J. J., & Jenkins, D. P. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw062 · Cited by 29
Critical Illness in Patients With Asplenia
O’Neal, H. R., Niven, A. S., & Karam, G. H. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.03.044 · Cited by 30
Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease
Buehler, P. W., Swindle, D. C., Pak, D. I., Ferguson, S. K., Majka, S. M., Karoor, V., Moldovan, R., Sintas, C., Black, J., Gentinetta, T., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.238 · Cited by 29
Ataga, K. I., Brittain, J. E., Jones, S., May, R., Delaney, J., Strayhorn, D., Desai, P. C., Redding‐Lallinger, R., Key, N. S., & Orringer, E. P. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08410.x · Cited by 31
Raat, N. J. H., Tabima, D. M., Specht, P. A. C., Tejero, J., Champion, H. C., Kim‐Shapiro, D. B., Baust, J., Mik, E. G., Hildesheim, M. E., Stasch, J., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5181 · Cited by 30
Self-citationRight Ventricular and Pulmonary Function in Sickle Cell Disease Patients with Pulmonary Hypertension
Akgül, F., Yalçın, F., Babayiğit, C., Seyfeli, E., Seydaliyeva, T., & Gali, E. (2006) · Pediatric Cardiology · doi:10.1007/s00246-006-1257-8 · Cited by 29
Landburg, P. P., Teerlink, T., Muskiet, F. A. J., Duits, A. J., & Schnog, J. B. (2008) · American Journal of Hematology · doi:10.1002/ajh.21184 · Cited by 30
Shizukuda, Y., Bolan, C. D., Tripodi, D. J., Yau, Y., Smith, K. P., Sachdev, V., Birdsall, C. W., Sidenko, S., Waclawiw, M. A., Leitman, S. F., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.055 · Cited by 29
Self-citationSullivan, K., Kissoon, N. “., Sandler, E. S., Gauger, C. A., Froyen, M., Duckworth, L. J., Brown, M., & Murphy, S. P. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181ec0ae5 · Cited by 30
Sickle Cell Disease: New Insights into Pathophysiology and Treatment
Inati, A. C., Koussa, S., Taher, A. T., & Perrine, S. P. (2008) · Pediatric Annals · doi:10.3928/00904481-20080501-07 · Cited by 31
Nguyen, V. T., Nassar, D., Batteux, F., Raymond, K., Tharaux, P., & Aractingi, S. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.005 · Cited by 30
Haematological Diseases in the Tropics
Thachil, J. V., Owusu‐Ofori, S., & Bates, I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-5101-2.00066-2 · Cited by 38
Rovedder, P. M. E., Ziegler, B., Pinotti, A. F. F., Barreto, S. S. M., & Dalcin, P. D. T. R. (2008) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132008000200004 · Cited by 28
Odhiambo, A., Perlman, D. H., Huang, H., Costello, C. E., Farber, H. W., Steinberg, M. H., McComb, M. E., & Klings, E. S. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3074 · Cited by 28
Mushemi-Blake, S., Melikian, N., Drašar, E., Bhan, A., Lunt, A. C., Desai, S. R., Greenough, A., Monaghan, M. J., Thein, S. L., & Shah, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135472 · Cited by 29
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.